BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25225890)

  • 1. Epidurals in patients receiving thromboprophylaxis with unfractionated heparin three times a day: the value of activated partial thromboplastin time testing.
    Pace M; Koury K; Gulur P
    Anesth Analg; 2014 Nov; 119(5):1215-8. PubMed ID: 25225890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-times-daily subcutaneous unfractionated heparin and neuraxial anesthesia: a retrospective review of 928 cases.
    Davis JJ; Bankhead BR; Eckman EJ; Wallace A; Strunk J
    Reg Anesth Pain Med; 2012; 37(6):623-6. PubMed ID: 22996202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Subcutaneous Unfractionated Heparin Prophylaxis on Activated Partial Thromboplastin Time: A Retrospective Evaluation.
    Thompson MH; Wilson SH; Toussaint BL; Jordan CL; Hayes GL; McKinzie BP; Wolf BJ; Field LC
    J Clin Anesth; 2016 Sep; 33():346-50. PubMed ID: 27555191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin.
    Price EA; Jin J; Nguyen HM; Krishnan G; Bowen R; Zehnder JL
    Ann Pharmacother; 2013 Feb; 47(2):151-8. PubMed ID: 23386070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varying Dosages of Subcutaneous Unfractionated Heparin and Activated Partial Thromboplastin Time in Hospitalized Antepartum Patients: A Retrospective Cohort Analysis.
    Elmofty DH; Tucker A; Wuenstel AM; Cheng PK; Fox E; Knoebel R; Liao C; Scavone B
    Anesth Analg; 2022 May; 134(5):1028-1034. PubMed ID: 35020621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged activated partial thromboplastin time in thromboprophylaxis with unfractionated heparin in patients undergoing cesarean section.
    Matsubara S; Usui R; Ohkuchi A; Okuno S; Izumi A; Watanabe T; Seo N; Suzuki M
    J Obstet Gynaecol Res; 2010 Feb; 36(1):58-63. PubMed ID: 20178528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfractionated Heparin TID Dosing Regimen Is Associated With a Lower Rate of Pulmonary Embolism When Compared With BID Dosing in Patients Undergoing Craniotomy.
    Thirunavu V; Kandula V; Shah P; Yerneni K; Karras CL; Abecassis ZA; Bloch O; Potts M; Jahromi B; Tate MC
    World Neurosurg; 2021 Sep; 153():e147-e152. PubMed ID: 34166830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidural hematoma following epidural analgesia in a patient receiving unfractionated heparin for thromboprophylaxis.
    Sandhu H; Morley-Forster P; Spadafora S
    Reg Anesth Pain Med; 2000; 25(1):72-5. PubMed ID: 10660245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thoracic Epidural Anesthesia and Prophylactic Three Times Daily Unfractionated Heparin Within an Enhanced Recovery After Surgery Pathway for Colorectal Surgery.
    Stone AB; Grant MC; Lau BD; Hobson DB; Streiff MB; Haut ER; Wu CL; Wick EC
    Reg Anesth Pain Med; 2017; 42(2):197-203. PubMed ID: 28079734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged activated partial thromboplastin time after prophylactic-dose unfractionated heparin in the post-operative neurosurgical setting: case series and management recommendations.
    Shusterman M; Grassl N; Berger K; De Sancho MT
    J Thromb Thrombolysis; 2020 Jan; 49(1):153-158. PubMed ID: 31456167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and Safety of Twice- Versus Thrice-Daily Subcutaneous Heparin for Venous Thromboembolism Prophylaxis at a Large Academic Medical Center.
    Wiethorn EE; Harrison S; Weeda ER; Bell CM
    Ann Pharmacother; 2022 May; 56(5):541-547. PubMed ID: 34459268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications.
    Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS
    Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin.
    Ratano D; Alberio L; Delodder F; Faouzi M; Berger MM
    Thromb Res; 2019 Mar; 175():53-58. PubMed ID: 30708169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing.
    Mahan CE; Pini M; Spyropoulos AC
    Intern Emerg Med; 2010 Aug; 5(4):299-306. PubMed ID: 20177819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery.
    Oladunjoye OO; Sleeper LA; Nair AG; Trenor CC; VanderPluym C; Kheir JN; Emani SM
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):332-340.e1. PubMed ID: 29709361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study.
    Samuel S; Allison TA; Sharaf S; Yau G; Ranjbar G; Mckaig N; Nguyen A; Escobar M; Choi HA
    J Clin Pharm Ther; 2016 Oct; 41(5):499-502. PubMed ID: 27381025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance.
    Takemoto CM; Streiff MB; Shermock KM; Kraus PS; Chen J; Jani J; Kickler T
    Am J Clin Pathol; 2013 Apr; 139(4):450-6. PubMed ID: 23525615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant effect at the time of epidural catheter removal in patients receiving twice-daily or once-daily low-molecular-weight heparin and continuous epidural analgesia after orthopedic surgery.
    Douketis JD; Kinnon K; Crowther MA
    Thromb Haemost; 2002 Jul; 88(1):37-40. PubMed ID: 12152674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.